Preparation of functional composite particles of salbutamol sulfate using a 4-fluid nozzle spray-drying technique

Chemical and Pharmaceutical Bulletin

Volumn 56, Issue 3, 2008, Pages 254-259

  Chen, Richer ^a   Okamoto, Hirokazu ^b   Danjo, Kazumi ^b  

^a Mintai Chemical Co Ltd   (Taiwan)

^b MEIJO UNIVERSITY   (Japan)

Author keywords

4 fluid nozzle spray drying; Eudragit ; Salbutamol sulfate; Solid dispersion; Sustained release

Indexed keywords

AMINE; ANTIASTHMATIC AGENT; ANTIMONY; CARBONYL DERIVATIVE; EUDRAGIT; EUDRAGIT RS; POLYMER; SALBUTAMOL SULFATE;

ARTICLE; COMPRESSION; CONTROLLED DRUG RELEASE; DIFFERENTIAL SCANNING CALORIMETRY; DRUG SOLUBILITY; DRY POWDER; HYDROGEN BOND; INFRARED SPECTROSCOPY; INHALER; MORPHOLOGY; NEBULIZATION; PARTICLE SIZE; PH; PHYSICAL CHEMISTRY; SCANNING ELECTRON MICROSCOPY; SIMULATION; SOLID; SPRAY DRYING; TECHNIQUE; X RAY DIFFRACTION;

ADMINISTRATION, INHALATION; ADRENERGIC BETA-AGONISTS; ALBUTEROL; ALGORITHMS; CALORIMETRY, DIFFERENTIAL SCANNING; DESICCATION; EXCIPIENTS; MICROSCOPY, ELECTRON, SCANNING; PARTICLE SIZE; POLYMERS; SOLUBILITY; SPECTROPHOTOMETRY, INFRARED; TABLETS; X-RAY DIFFRACTION;

EID: 41549099985     PISSN: 00092363     EISSN: 13475223     Source Type: Journal    
DOI: 10.1248/cpb.56.254     Document Type: Article

References (25)

1. Simonelli A. P., Mehta S. C., Higuchi W. I., J. Pharm. Sci., 58, 538-549 (1969).
2. Simonelli A. P., Mehta S. C., Higuchi W. I., J. Pharm. Sci., 65, 355-361 (1976).
3. Mcginity J. W., Maincent P., Steinfink H., J. Pharm. Sci., 73, 1441-1444 (1984).
4. Law S. L., Lo W. Y., Lin F. M., Chaing C. H., Int. J. Pharm., 84, 161-166 (1992).
5. Mura P., Manderioli A., Bramanti G., Ceccarelli L., Drug Develop. Ind. Pharm., 22, 909-916 (1996).
6. Kumar S. G. V., Mishra D. N., Yakugaku Zasshi, 126, 657-664 (2006).
7. Sekikawa H., Naganuma T., Fujiwara J., Nakano M., Arita T., Chem. Pharm. Bull., 27, 31-37 (1979).
8. Itoh S., Tagaki A., Tanabe K., Yamazaki M., Yakuzaigaku, 54, 180-184 (1994).
9. Lo W. Y., Law S. L., Drug Develop. Ind. Pharm., 22, 231-236 (1996).
10. Tantishaiyakul V., Kaewnopparat N., Ingkatawornwong S., Int. J. Pharm., 143, 59-66 (1996).
11. Ozeki T., Yuasa H., Kanaya Y., Oishi K., Chem. Pharm. Bull., 43, 660-665 (1995).
12. Corrigan O. I., Holohan E. M., J. Pharm. Pharmacol., 36, 217-221 (1984).
13. Corrigan O. I., Holohan E. M., Reilly M. R., Drug Develop. Ind. Pharm., 11, 677-695 (1985).
14. Emara L. H., Badr R. M., Elbary A. A., Drug Develop. Ind. Pharm., 28, 795-807 (2002).
15. Yamashita K., Nakate T., Okimoto K., Ohike A., Tokunaga Y., Ibuki R., Higaki K., Kimura T., Int. J. Pharm., 267, 79-91 (2003).
16. He P., Davis S. S., Illum. L., Int. J. Pharm., 187, 53-65 (1999).
17. Shaikh N. A., Abidi S. E., Block L. H., Drug Develop. Ind. Pharm., 13, 1345-1369 (1987).
18. Corrigan D. O., Healy A. M., Corrigan O. I., Eur. J. Pharm., 62, 295-305 (2006).
19. Chen R., Okamoto H., Danjo K., Chem. Pharm. Bull., 54, 948-953 (2006).
20. Chen R., Okamoto H., Danjo K., J. Drug Del. Sci. Tech., 17, 129-135 (2007).
21. Takahashi H., Chen R., Okamoto H., Danjo K., Chem. Pharm. Bull., 53, 37-41 (2005).
22. Kristmundsdottir T., Gudmundsson O. S., Ingvarsdottir K., Int. J. Pharm., 137, 159-165 (1996).
23. Ozeki T., Beppu S., Mizoe T., Takashima Y., Yuasa H., Okada H., J. Controlled Release, 107, 387-394 (2005).
24. Ozeki T., Beppu S., Mizoe T., Takashima Y., Yuasa H., Okada H., Pharm. Res., 23, 177-183 (2006).
25. Beppu S., Ozeki T., Sasaki Y., Mizoe T., Takashima Y., Yuasa H., Okada H., Yakuzaigaku, 63, 228-237 (2003).